126 related articles for article (PubMed ID: 26956768)
1. Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway.
Panneerselvam J; Xie G; Che R; Su M; Zhang J; Jia W; Fei P
J Proteome Res; 2016 Apr; 15(4):1333-41. PubMed ID: 26956768
[TBL] [Abstract][Full Text] [Related]
2. FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer.
Panneerselvam J; Park HK; Zhang J; Dudimah FD; Zhang P; Wang H; Fei P
Cell Cycle; 2012 Aug; 11(15):2947-55. PubMed ID: 22828653
[TBL] [Abstract][Full Text] [Related]
3. FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth.
Zhang J; Zhao D; Park HK; Wang H; Dyer RB; Liu W; Klee GG; McNiven MA; Tindall DJ; Molina JR; Fei P
J Clin Invest; 2010 May; 120(5):1524-34. PubMed ID: 20407210
[TBL] [Abstract][Full Text] [Related]
4. Fanconi Anemia complementation group C protein in metabolic disorders.
Nepal M; Ma C; Xie G; Jia W; Fei P
Aging (Albany NY); 2018 Jun; 10(6):1506-1522. PubMed ID: 29930218
[TBL] [Abstract][Full Text] [Related]
5. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
[TBL] [Abstract][Full Text] [Related]
6. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.
Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ
Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163
[TBL] [Abstract][Full Text] [Related]
7. Mutated Fanconi anemia pathway in non-Fanconi anemia cancers.
Shen Y; Lee YH; Panneerselvam J; Zhang J; Loo LW; Fei P
Oncotarget; 2015 Aug; 6(24):20396-403. PubMed ID: 26015400
[TBL] [Abstract][Full Text] [Related]
8. Fanconi anemia and ubiquitination.
Zhang Y; Zhou X; Huang P
J Genet Genomics; 2007 Jul; 34(7):573-80. PubMed ID: 17643942
[TBL] [Abstract][Full Text] [Related]
9. IL-6, IL-8, MMP-2, MMP-9 are overexpressed in Fanconi anemia cells through a NF-κB/TNF-α dependent mechanism.
Epanchintsev A; Shyamsunder P; Verma RS; Lyakhovich A
Mol Carcinog; 2015 Dec; 54(12):1686-99. PubMed ID: 25358651
[TBL] [Abstract][Full Text] [Related]
10. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia.
Rickman KA; Lach FP; Abhyankar A; Donovan FX; Sanborn EM; Kennedy JA; Sougnez C; Gabriel SB; Elemento O; Chandrasekharappa SC; Schindler D; Auerbach AD; Smogorzewska A
Cell Rep; 2015 Jul; 12(1):35-41. PubMed ID: 26119737
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
[TBL] [Abstract][Full Text] [Related]
13. Fanconi anemia type C-deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8.
Platzbecker U; Kurre P; Guardiola P; Ward JL; Radich JP; Kiem HP; Deeg HJ
Exp Hematol; 2004 Sep; 32(9):815-21. PubMed ID: 15345282
[TBL] [Abstract][Full Text] [Related]
14. Lowered expression levels of a tumor suppressor gene - caveolin-1 within dysregulated gene networks of Fanconi anemia.
Shyamsunder P; Vidyasekar P; Shukla AR; Mohan S; Verma RS
Gene; 2013 Sep; 527(2):521-8. PubMed ID: 23845778
[TBL] [Abstract][Full Text] [Related]
15. Analysis of a FANCE Splice Isoform in Regard to DNA Repair.
Bouffard F; Plourde K; Bélanger S; Ouellette G; Labrie Y; Durocher F
J Mol Biol; 2015 Sep; 427(19):3056-73. PubMed ID: 26277624
[TBL] [Abstract][Full Text] [Related]
16. BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells.
Wang H; Bierie B; Li AG; Pathania S; Toomire K; Dimitrov SD; Liu B; Gelman R; Giobbie-Hurder A; Feunteun J; Polyak K; Livingston DM
Mol Cell; 2016 Jul; 63(2):277-292. PubMed ID: 27373334
[TBL] [Abstract][Full Text] [Related]
17. [Functions of FANCL in primordial germ cell formation and Fanconi anemia].
Zhao QG; Lu BS; Huang PT
Yi Chuan Xue Bao; 2005 Sep; 32(9):993-1000. PubMed ID: 16201245
[TBL] [Abstract][Full Text] [Related]
18. Novel homozygous FANCL mutation and somatic heterozygous SETBP1 mutation in a Chinese girl with Fanconi Anemia.
Wu W; Liu Y; Zhou Q; Wang Q; Luo F; Xu Z; Geng Q; Li P; Zhang HZ; Xie J
Eur J Med Genet; 2017 Jul; 60(7):369-373. PubMed ID: 28419882
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
